Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

Mejean A.; Ravaud A.; Thezenas S.; Colas S.; Beauval J. -B.; Bensalah K.; Geoffrois L.; Thiery-Vuillemin A.; Cormier L.; Lang H.; Guy L.; Gravis G.; Rolland F.; Linassier C.; Lechevallier E.; Beisland C.; Aitchison M.; Oudard S.; Patard J. -J.; Theodore C.; Chevreau C.; Laguerre B.; Hubert J.; Gross-Goupil M.; Bernhard J. -C.; Albiges L.; Timsit M. -O.; Lebret T.; Escudier B.

首页> 外文期刊>The New England journal of medicine >Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

【24h】

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

机译：单独的Sunitinib或在转移性肾细胞癌中肾切除术后

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUND

机译：背景

著录项

来源
《The New England journal of medicine》 |2018年第5期|共11页
作者
Mejean A.; Ravaud A.; Thezenas S.; Colas S.; Beauval J. -B.; Bensalah K.; Geoffrois L.; Thiery-Vuillemin A.; Cormier L.; Lang H.; Guy L.; Gravis G.; Rolland F.; Linassier C.; Lechevallier E.; Beisland C.; Aitchison M.; Oudard S.; Patard J. -J.; Theodore C.; Chevreau C.; Laguerre B.; Hubert J.; Gross-Goupil M.; Bernhard J. -C.; Albiges L.; Timsit M. -O.; Lebret T.; Escudier B.;
展开▼
作者单位

Univ Paris 05 Hop Europeen Georges Pompidou AP HP Dept Urol Paris France;

Bordeaux Univ Hosp Dept Med Oncol Bordeaux France;

Univ Montpellier Canc Inst Montpellier Biometr Unit Montpellier France;

AP HP Paris Descartes Necker Cochin Clin Res Unit Paris France;

CHU Rangueil Dept Urol Toulouse France;

Univ Rennes Dept Urol Rennes France;

Inst Cancerol Lorraine Dept Med Oncol Vandoeuvre Les Nancy France;

CHU Besancon Dept Med Oncol Oncol Besancon France;

CHU Francois Mitterrand Dept Urol Dijon France;

CHU Strasbourg Translat Med Federat Strasbourg Dept Urol Strasbourg France;

Gabriel Montpied Hosp Dept Urol Clermont Ferrand France;

CNRS Ctr Rech Cancerol Marseille Dept Med Oncol INSERM UMR 1068 UMR 7258 Marseille France;

Inst Cancerol Ouest Dept Med Oncol Nantes France;

CHU Bretonneau Dept Med Oncol Tours France;

Aix Marseille Univ Hop Concept Dept Urol Marseille France;

Haukeland Hosp Dept Urol Bergen Norway;

Royal Free Hosp Dept Urol London England;

Univ Paris 05 Hop Europeen Georges Pompidou AP HP Dept Med Oncol Paris France;

Mt de Marsan Gen Hosp Dept Urol Mt De Marsan France;

Hop Foch Dept Med Oncol Suresnes France;

Inst Univ Canc Toulouse Oncopole Dept Med Oncol Toulouse France;

Ctr Eugene Marquis Dept Med Oncol Rennes France;

CHU Nancy INSERM Imagerie Adaptat Diagnost &

Intervent Dept Urol U1254 Brabois France;

Ctr Hosp Univ CHU Bordeaux Hop St Andre Dept Med Oncol Bordeaux France;

CHU Bordeaux Dept Urol Bordeaux France;

Gustave Roussy Inst Dept Med Oncol 114 Rue Edouard Vaillant F-94800 Villejuif France;

Univ Paris 05 Hop Europeen Georges Pompidou AP HP Dept Urol Paris France;

Hop Foch Dept Urol Suresnes France;

Gustave Roussy Inst Dept Med Oncol 114 Rue Edouard Vaillant F-94800 Villejuif France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类 R23;
关键词

相似文献

外文文献
中文文献
专利

1. Reply to Michael Staehler, Dena Battle, Axel Bex, Hans Hammers, and Daniel George's Letter to the Editor re: Arnaud Mejean, Alain Ravaud, Simon Thezenas, et al. Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. Eur Urol 2018;74:842-3 Lymphocyte Phenotype and Timing of Radical Nephrectomy in Patients Treated with Immunocheckpoint Inhibitors for Renal Cell Carcinoma [J] . Santoni Matteo, Montironi Rodolfo, Battelli Nicola, European urology . 2019,第3期

机译：回复Michael Staehler，Dena Battle，Axel Bex，Hans Hammers和Daniel George的信Re：Arnaud Mejean，Alain Ravaud，Simon Thezenas，等。单独的Sunitinib或在转移性肾细胞癌中肾切除术后。 EUR UROL 2018; 74：842-3淋巴细胞表型和自由基肾切除术治疗肾细胞癌治疗的患者的激进肾切除术
2. Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma [J] . Mejean A., Ravaud A., Thezenas S., The New England journal of medicine . 2018,第5期

机译：单独的Sunitinib或在转移性肾细胞癌中肾切除术后
3. Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma [J] . Michael Staehler, Dena Battle, Axel Bex, European urology . 2018,第6期

机译：Re：Sunitinib单独或在转移性肾细胞癌中的肾切除术后
4. When to Treat Metastatic Renal Cell Carcinoma Comorbidities, Systemic Therapy, and Active Surveillance in Metastatic Kidney Cancer [C] . Brian I. Rini Genitourinary Cancers Symposium . 2012

机译：何时治疗转移性肾细胞癌的组合，全身治疗，以及在转移性肾癌中的活跃监测
5. Methodological Approaches for Conducting Claims-Based Studies in Patients Diagnosed with Metastatic Renal Cell Carcinoma [D] . Chun, Danielle S. 2021

机译：用于诊断转移性肾细胞癌的患者的基于权利要求的基于权利要求的方法论方法
6. Adjuvant sunitinib or sorafenib for high-risk non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind placebo-controlled randomised phase 3 trial [O] . Naomi B Haas, Judith Manola, Robert G Uzzo, -1

机译：高危非转移性肾细胞癌（ECOG-ACRIN E2805）的辅助舒尼替尼或索拉非尼：一项双盲安慰剂对照随机3期试验
7. Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy [O] . Ravaud A, Motzer RJ, Pandha HS, 2016

机译：肾切除术后高危肾细胞癌的佐尼替尼辅助治疗

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅